UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rapid COVID-19 vaccine rollout: immense success but challenges ahead

The Lancet infectious diseases, 2022-03, Vol.22 (3), p.302-304

2022

Volltextzugriff (PDF)

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

The Lancet infectious diseases, 2021-07, Vol.21 (7), p.962-974

2021

Volltextzugriff (PDF)

Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e962-e973

2022

Volltextzugriff (PDF)

Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis

Clinical infectious diseases, 2020-12, Vol.71 (12), p.3196-3203

2020

Volltextzugriff (PDF)

Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

The Lancet. Public health, 2021-03, Vol.6 (3), p.e175-e183

2021

Volltextzugriff (PDF)

RSV immunisation in infants: weighing the options

The Lancet regional health. Europe, 2024-03, Vol.38, p.100867-100867, Article 100867

2024

Volltextzugriff (PDF)

Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies

BMC medicine, 2020-03, Vol.18 (1), p.38-38, Article 38

2020

Volltextzugriff (PDF)

A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries

Nature communications, 2021-10, Vol.12 (1), p.5968-11, Article 5968

2021

Volltextzugriff (PDF)

What are economic costs and when should they be used in health economic studies?

Cost effectiveness and resource allocation, 2023-05, Vol.21 (1), p.31-31, Article 31

2023

Volltextzugriff (PDF)

Estimating the opportunity costs of bed‐days

Health economics, 2018-03, Vol.27 (3), p.592-605

2018

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation

Value in health, 2020-03, Vol.23 (3), p.309-318

2020

Volltextzugriff (PDF)

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study

The Lancet regional health. Europe, 2022-01, Vol.12, p.100267-100267, Article 100267

2022

Volltextzugriff (PDF)

Seasonality of acute kidney injury phenotypes in England: an unsupervised machine learning classification study of electronic health records

BMC nephrology, 2023-08, Vol.24 (1), p.234-234, Article 234

2023

Volltextzugriff (PDF)

The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study

BMC public health, 2023-07, Vol.23 (1), p.1350-13, Article 1350

2023

Volltextzugriff (PDF)

Predicting subnational incidence of COVID-19 cases and deaths in EU countries

BMC infectious diseases, 2024-02, Vol.24 (1), p.204-20, Article 204

2024

Volltextzugriff (PDF)

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients

Clinical infectious diseases, 2018-08, Vol.67 (5), p.693-700

2018

Volltextzugriff (PDF)

The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment

BMC medicine, 2021-02, Vol.19 (1), p.52-52, Article 52

2021

Volltextzugriff (PDF)

The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant

Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-05, Vol.26 (20), p.1

2021

Volltextzugriff (PDF)

Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events

Nature communications, 2022-04, Vol.13 (1), p.1956-1956, Article 1956

2022

Volltextzugriff (PDF)

Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level

BMC medicine, 2022-02, Vol.20 (1), p.86-15, Article 86

2022

Volltextzugriff (PDF)

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

Health technology assessment (Winchester, England), 2020-09, Vol.24 (47), p.1-86

2020

Volltextzugriff (PDF)

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis

The Lancet regional health. Europe, 2022-06, Vol.17, p.100381, Article 100381

2022

Volltextzugriff (PDF)

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?

Expert review of pharmacoeconomics & outcomes research, 2018-09, Vol.18 (5), p.475-486

2018

Volltextzugriff (PDF)

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

BMC infectious diseases, 2022-06, Vol.22 (1), p.556-556, Article 556

2022

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(88)
Humans
(76)
Covid-19
(31)
Male
(23)
Female
(21)
Sars-Cov-2
(21)
Aged
(20)
Biological And Medical Sciences
(20)
Severe Acute Respiratory Syndrome Coronavirus 2
(20)
Adult
(19)
Middle Aged
(19)
Covid-19 - Epidemiology
(18)
Infectious Diseases
(17)
Pandemics
(16)
Public Health
(16)
Coronaviruses
(15)
Covid-19 - Prevention & Control
(15)
Epidemics
(15)
Health Care Sciences & Services
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rapid COVID-19 vaccine rollout: immense success but challenges ahead

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls

Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis

Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

RSV immunisation in infants: weighing the options

Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies

A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries

What are economic costs and when should they be used in health economic studies?

Estimating the opportunity costs of bed‐days

Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study

Seasonality of acute kidney injury phenotypes in England: an unsupervised machine learning classification study of electronic health records

The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study

Predicting subnational incidence of COVID-19 cases and deaths in EU countries

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis

The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment

The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant

Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events

Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

Suchergebnisse filtern